US Stock MarketDetailed Quotes

Novo-Nordisk A/S (NVO)

Watchlist
  • 38.830
  • +0.110+0.28%
Close Mar 11 15:59 ET
  • 38.500
  • -0.330-0.85%
Post 20:01 ET
173.38BMarket Cap10.89P/E (TTM)

About Novo-Nordisk A/S Company

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv?rd, Denmark.

Company Profile

SymbolNVO
Company NameNovo-Nordisk A/S
Listing DateJul 9, 1981
ISINUS6701002056
Founded1923
CEOMr. Maziar Mike Doustdar
MarketNYSE
Employees69505
Securities TypeDR
ADS Ratio1 : 1
Fiscal Year Ends12-31
AddressNovo Allé 1
CityBagsv?rd
ProvinceCapital Region
CountryDenmark
Zip Code2880
Phone45-44-44-88-88

Company Executives

  • Name
  • Position
  • Salary
  • Maziar Mike Doustdar
  • President and Chief Executive Officer
  • --
  • Martin Holst Lange
  • Executive Vice President, Research and Development and Chief Scientific Officer
  • --
  • Karsten Munk Knudsen
  • Executive Vice President and Chief Financial Officer
  • 26.80M
  • Thilde Hummel Bogebjerg
  • Executive Vice President, Enterprise IT and Quality
  • --
  • Tania Sabroe
  • Executive Vice President, People, Organisation and Corporate Affairs
  • --
  • Elin Jager
  • Senior Vice President, Chief of Staff and Corporate Strategy and Sustainability
  • --
  • Ludovic Helfgott
  • Executive Vice President, Product and Portfolio Strategy
  • --
  • Kasper Bodker Mejlvang
  • Executive Vice President, CMC and Product Supply
  • --
  • Jamey Millar
  • Executive Vice President, Us Operations
  • --
  • Hong Chow
  • Executive Vice President, Product and Portfolio Strategy
  • --
  • Emil Kongshoj Larsen
  • Executive Vice President, International Operations
  • --
  • Lars Rebien Sorensen
  • Chairman of the Board
  • --
  • Dr. Cees de Jong
  • Vice Chairman of the Board
  • --
  • Mette Bojer Jensen
  • Director
  • 1.30M
  • Liselotte Hyveled
  • Director
  • 1.20M
  • Elisabeth Dahl Christensen
  • Director
  • 1.10M
  • Britt Meelby Jensen
  • Director
  • --
  • Kasim Kutay
  • Director
  • 1.50M
  • Stephan Engels
  • Independent Director
  • --
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. On March 11 local time, Trump once again Show More